The UK grocery market is abuzz with the latest health trend: "Jab-uary", a marketing term coined by supermarkets to capitalize on the growing demand for diet foods aimed at people taking weight-loss drugs. The buzz surrounds pricey meals designed to meet the nutritional needs of those using GLP-1 agonists, such as Wegovy and Mounjaro.
High street names like Marks & Spencer, Morrisons, Asda, Ocado, and Co-op are among those jumping on the bandwagon. Ocado's new virtual "weight management" aisle boasts a curated range of products catering to weight-loss diets, from tiny portions of steak at £3.50 to high-end powdered greens supplements for £107 per pack.
The online supermarket notes strong demand for protein-rich staples like steak, chicken, cottage cheese, and health drinks and vitamins. Ocado is also offering M&S's "Nutrient Dense" range of meals, snacks, and drinks touting "high amounts of nutrients per calorie". The Co-op, meanwhile, is selling its own line of "mini meals" – 250g-280g pots inspired by global cuisines at £3.50 each.
However, experts warn that the trend may be overhyped. Jonny Forsyth, a senior analyst at Mintel, says only about 6% of UK adults are taking GLP-1 drugs, and the hype around them is having an "outsize influence" on consumer behavior. The focus on high protein foods could also be fueling other diet trends.
Supermarkets like Sainsbury's and Tesco are introducing new products to cater to this growing demand. The retailer has launched a "Small but Mighty" range of low-calorie ready meals, while the latter is keeping a close eye on how the GLP-1 trend develops.
Despite the hype, there are concerns about whether supermarkets can make small portions work as a virtue in a market where consumers are fed up with shrinkflation. The price premium for these products may also be a drawback, with some experts arguing that they come at a significant cost to consumers.
Markets and food manufacturers must now navigate this complex landscape, weighing the need to adapt to changing consumer behavior against the risks of alienating customers who are already looking to make healthier choices – often by cutting back on discretionary spending.
High street names like Marks & Spencer, Morrisons, Asda, Ocado, and Co-op are among those jumping on the bandwagon. Ocado's new virtual "weight management" aisle boasts a curated range of products catering to weight-loss diets, from tiny portions of steak at £3.50 to high-end powdered greens supplements for £107 per pack.
The online supermarket notes strong demand for protein-rich staples like steak, chicken, cottage cheese, and health drinks and vitamins. Ocado is also offering M&S's "Nutrient Dense" range of meals, snacks, and drinks touting "high amounts of nutrients per calorie". The Co-op, meanwhile, is selling its own line of "mini meals" – 250g-280g pots inspired by global cuisines at £3.50 each.
However, experts warn that the trend may be overhyped. Jonny Forsyth, a senior analyst at Mintel, says only about 6% of UK adults are taking GLP-1 drugs, and the hype around them is having an "outsize influence" on consumer behavior. The focus on high protein foods could also be fueling other diet trends.
Supermarkets like Sainsbury's and Tesco are introducing new products to cater to this growing demand. The retailer has launched a "Small but Mighty" range of low-calorie ready meals, while the latter is keeping a close eye on how the GLP-1 trend develops.
Despite the hype, there are concerns about whether supermarkets can make small portions work as a virtue in a market where consumers are fed up with shrinkflation. The price premium for these products may also be a drawback, with some experts arguing that they come at a significant cost to consumers.
Markets and food manufacturers must now navigate this complex landscape, weighing the need to adapt to changing consumer behavior against the risks of alienating customers who are already looking to make healthier choices – often by cutting back on discretionary spending.